Company Filing History:
Years Active: 2019-2022
Title: Gregory Olson: Innovator in Vitamin D Detection
Introduction
Gregory Olson is a notable inventor based in Lakeland, MN (US), recognized for his contributions to the field of medical diagnostics. He holds a total of four patents, showcasing his innovative approach to detecting vital biomarkers in biological samples.
Latest Patents
One of Olson's latest patents is focused on methods for detecting 1,25-dihydroxyvitamin D and related antibodies. This patent discloses an assay method that selectively detects 1,25-dihydroxyvitamin D in biological fluid samples. The method involves adjusting the pH of the test sample to a range of 6-9 and adding a receptor protein that comprises the Ligand Binding Domain of the Vitamin D Receptor (VDR-LBD). This process results in the formation of a VDR-LBD/1,25-dihydroxyvitamin D complex, which can be detected using a capture moiety that specifically binds to the complex. The assay is preferably a sandwich immunoassay.
Another significant patent by Olson relates to the use of 1,25-dihydroxyvitamin D values in ratio with parathyroid hormone (PTH) as a prognostic biomarker. This invention provides a method for predicting or stratifying the risk of worsening renal function in patients at risk of renal injury. By measuring levels of 1,25-dihydroxyvitamin D alongside PTH levels, a ratio can be established that indicates the risk of worsening renal function.
Career Highlights
Gregory Olson is currently employed at Diasorin S.p.a., a company known for its advancements in diagnostic solutions. His work has significantly impacted the field of medical diagnostics, particularly in the detection of vitamin D and its implications for renal health.
Collaborations
Olson collaborates with talented individuals such as Joshua Soldo and Michael Lutterman, contributing to a dynamic team focused on innovative solutions in diagnostics.
Conclusion
Gregory Olson's work in the field of vitamin D detection exemplifies the importance of innovation in medical diagnostics. His patents not only advance scientific understanding but also have the potential to improve patient outcomes in renal health.